Squarepoint Ops LLC Edwards Lifesciences Corp Call Options Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	SELL	$64.54 - $75.92 $11.6 Million - $13.7 Million	-180,200 Reduced 83.19%	36,400 $2.69 Million
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $12.1 Million - $19 Million	203,000 Added 1492.65%	216,600 $14.3 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $463,650 - $518,705	-5,500 Reduced 28.8%	13,600 $1.26 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $855,972 - $1.13 Million	11,800 Added 161.64%	19,100 $1.83 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $1.92 Million - $2.42 Million	-31,100 Reduced 80.99%	7,300 $556,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $3.13 Million - $3.62 Million	38,400 New	38,400 $3.62 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $170,192 - $209,088	-1,600 Reduced 6.81%	21,900 $2.84 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $164,656 - $196,400	1,600 Added 7.31%	23,500 $2.66 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $1.72 Million - $1.99 Million	21,900 New	21,900 $1.83 Million

1,383

487M

6.71M

3.17M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.